Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Aristotle University Of Thessaloniki
University of California, San Francisco
University of Florida
Dana-Farber Cancer Institute
Sun Yat-sen University
Nova Scotia Health Authority
Duke University
Children's Cancer Hospital Egypt 57357
Capital Medical University
Capital Medical University
Washington University School of Medicine
RenJi Hospital
Duke University
Fundacion Clinic per a la Recerca Biomédica
Peking University First Hospital